Art

J-GLOBAL ID：201302268620622017   Reference number：13A0937926

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer

ゲムシタビン難治性胆道癌のためのS-1の多施設第II相試験

Author (10)： SUZUKI Eiichiro (Kyorin Univ. School of Medicine, Dep. of Internal Medicine, Medical Oncology, 6-20-2, Shinkawa, 181-8611, Mitaka ...) ,  IKEDA Masafumi (National Cancer Center Hospital East, Div. of Hepatobiliary and Pancreatic Medical Oncology, Kashiwa, JPN) ,  OKUSAKA Takuji (National Cancer Center Hospital, Div. of Hepatobiliary and Pancreatic Oncology, Tokyo, JPN) ,  NAKAMORI Shoji (National Hospital Organization Osaka National Hospital, Dep. of Surgery, Osaka, JPN) ,  OHKAWA Shinichi (Kanagawa Cancer Center, Div. of Hepatobiliary and Pancreatic Medical Oncology, Yokohama, JPN) ,  NAGAKAWA Tatsuya (Sapporo Kosei General Hospital, Dep. of Gastroenterology, Sapporo, JPN) ,  BOKU Narikazu (Shizuoka Cancer Center, Div. of Gastrointestinal Oncology, Shizuoka, JPN) ,  YANAGIMOTO Hiroaki (Kansai Medical Univ., Dep. of Surgery, Hirakata, JPN) ,  SATO Tosiya (Kyoto Univ. School of Public Health, Dep. of Biostatistics, Kyoto, JPN) ,  FURUSE Junji (Kyorin Univ. School of Medicine, Dep. of Internal Medicine, Medical Oncology, 6-20-2, Shinkawa, 181-8611, Mitaka ...)
Material： Cancer Chemotherapy and Pharmacology  (Cancer Chemother Pharmacol)
Volume： 71  Issue： 5  Page： 1141-1146  Publication year： May. 2013 
JST Material Number： D0065D  ISSN： 0344-5704  CODEN： CCPHDZ  Document type： Article
Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Terms in the title (5)： ゲムシタビン ,  胆道癌 ,  S-1 ,  施設 ,  第II相試験